Health Trials

B Lineage Lymphoblastic Lymphoma

2

Review clinical trials related to B Lineage Lymphoblastic Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

This study will determine the safety and efficacy of moving to a second-generation manufacturing process using the CliniMACS Prodigy platform to manufacture huCART19 cells for patients with B cell Acute Lymphoblastic Leukemia (B-ALL).

Participants needed: 115
Trial details
Phase: Phase 1, Phase 2Age: 0-29Biological sex: AllType: InterventionalSponsor: Stephan Grupp MD PhDUpdated: May 26, 2026Locations: 1
Eligibility criteria

Signed Informed Informed Consent

Active hepatitis B or active hepatitis C [+8]

Read more
Status: Recruiting

Co-administration of CART22-65s and huCART19 for B-ALL

This study will evaluate the safety and efficacy of administering two CAR T cell products, huCART19 and CART22-65s, in children with advanced B cell Acute Lymphoblastic Leukemia (B-ALL).

Participants needed: 93
Trial details
Phase: Phase 1, Phase 2Age: Up to 29Biological sex: AllType: InterventionalSponsor: Stephan Grupp MD PhDUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Signed informed consent form [+7]

Active hepatitis B or active hepatitis C [+6]

Read more